CJL
VRTX icon

Cyrus J. Lawrence’s Vertex Pharmaceuticals VRTX Stock Holding History

Cyrus J. Lawrence’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$665K Sell
1,373
-19,011
-93% -$8.86M 2.52% 17
2024
Q4 		$8.21M Sell
20,384
-6,313
-24% -$2.93M 1.59% 30
2024
Q3 		$12.4M Buy
26,697
+209
+0.8% +$100K 2.44% 14
2024
Q2 		$12.4M Buy
26,488
+12,769
+93% +$5.54M 2.52% 13
2024
Q1 		$5.73M Buy
+13,719
New +$5.8M 1.27% 37

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Cyrus J. Lawrence's VRTX Position: Q1 2025 in Review

Cyrus J. Lawrence reduced its Vertex Pharmaceuticals (VRTX) stake by 93% in Q1 2025, selling an estimated $8.86M and leaving 1,373 shares worth $665K. The position accounts for 2.52% of the portfolio, ranked #17.

Cyrus J. Lawrence first reported a position in VRTX in Q1 2024 and has held it in 5 quarters since. The position peaked at $12.4M in Q3 2024. 1,616 funds tracked by Wall St. Rank hold VRTX as of Q1 2025.

  • Cyrus J. Lawrence held 1,373 shares of Vertex Pharmaceuticals worth $665K as of Q1 2025.
  • Cyrus J. Lawrence sold 19,011 Vertex Pharmaceuticals shares in Q1 2025, an estimated $8.86M.
  • Vertex Pharmaceuticals made up 2.52% of Cyrus J. Lawrence's portfolio in Q1 2025, its #17 holding.
  • Cyrus J. Lawrence first reported a position in Vertex Pharmaceuticals in Q1 2024 and has held it in 5 quarters since.
  • Cyrus J. Lawrence's Vertex Pharmaceuticals position peaked at $12.4M in Q3 2024.
  • 1,616 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2025.

Based on Cyrus J. Lawrence's 13F filing for Q1 2025, filed 15 May 2025.